相关产品推荐更多 >

TAGL2 Rabbit pAb, PE-Cy5.5 conjugated(bs-2977R-PE-Cy5.5)-100ul
¥2980
C1orf192 Rabbit pAb(bs-15051R)-50ul/100ul/200ul
¥1180
NMDAR1 Recombinant Rabbit mAb(bsm-52950R)-50ul/100ul/25ul
¥800
phospho-MLF1 Interacting Protein (Thr78) Rabbit pAb(bs-5753R)-50ul/100ul/200ul
¥1180
ZNF214 Rabbit pAb, AP conjugated(bs-12801R-AP)-100ul
¥2980
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 应用范围:
产品信息以Bioss网站为准
- 规格:
50ul/100ul/200ul
| 规格: | 50ul | 产品价格: | ¥1180.0 |
|---|---|---|---|
| 规格: | 100ul | 产品价格: | ¥1980.0 |
| 规格: | 200ul | 产品价格: | ¥2800.0 |
| 产品编号 | bs-0774R |
| 英文名称 | Mouse IgA Rabbit pAb |
| 中文名称 | 小鼠IgA抗体 |
| 英文别名 | A2m marker; Ig alpha chain C region; Igh2; IGHA 1; IGHA 2; IGHA1; IGHA2; Ig alpha 1; Ig Am1; Ig Am2; Ig heavy chain 2; Ig heavy constant alpha 1; Immunoglobulin heavy constant alpha; MGC102857. |
| 产品应用 | WB=1:500-2000 Not yet tested in other applications. |
| 交叉反应 | Mouse |
| 抗体来源 | Rabbit |
| 免疫原 | Mouse IgA protein purified from serum |
| 亚型 | IgG |
| 性状 | Liquid |
| 纯化方法 | affinity purified by Protein A from plasma |
| 克隆类型 | Polyclonal |
| 理论分子量 | 55 kDa |
| 浓度 | 1mg/ml |
| 储存液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 研究领域 | Immunology > Immunoglobulins > Heavy Chain > IgA |
| 亚细胞定位 | Secreted. |
| 保存条件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 背景资料 | Monomeric IgA constitutes 5-15 % of the serum immunoglobulins whereas dimeric IgA is localized to mucosa surfaces such as saliva, gastrointestinal secretion, bronchial fluids and milk. Mucosal IgA plays a major role in host defence by neutralising infectious agents at mucosal surfaces. The production is usually local and antigen specific IgA producing B-cells can be found in regions under the lamina propria where they mature into dimeric IgA producing plasma cells. IgA deficiency is the most common immunodeficiency that may affect both serum and mucosal produced IgA. |
| 应用 | 推荐稀释比例 |
| {WB} | {1:500-2000} |

Lane 1: Serum (Mouse) at 40 ug
Lane 2: Small intestine (Mouse) Lysate at 40 ug
Lane 3: Lung (Mouse) Lysate at 40 ug
Primary: Anti-Mouse IgA (bs-0774R) at 1/1000 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 55 kD
Observed band size: 60 kD
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验[IF={{ 7.7 }}] {Di Chen. et al. Polysaccharide from Areca catechu L. inflorescence enhances the intestinal mucosal immunity to maintain immune homeostasis. INT J BIOL MACROMOL. 2024 Oct;278:134900} {IF} {Mouse}
[IF={{ 7.543 }}] {Yao L et al. The proteasome activator REGγ counteracts immunoproteasome expression and autoimmunity. J Autoimmun. 2019 Jun 3.} {IF} {Mouse}
[IF={{ 7.5 }}] {Zhibo Zeng. et al. Lactobacillus plantarum modulate gut microbiota and intestinal immunity in cyclophosphamide-treated mice model. BIOMED PHARMACOTHER. 2023 Dec;169:115812} {IHC} {Mouse}
[IF={{ 6.656 }}] {Gaofeng Cai. et al. The secretion of sIgA and dendritic cells activation in the intestinal of cyclophosphamide-induced immunosuppressed mice are regulated by Alhagi honey polysaccharides. PHYTOMEDICINE. 2022 Aug;103:154232} {Other} {Human}
[IF={{ 6.064 }}] {Yanqiao Wen. et al. Regulation of Yujin Powder alcoholic extracts on ILC3s-TD IgA-colonic mucosal flora axis of DSS-induced ulcerative colitis.. FRONT MICROBIOL. 2022 Oct;13:1039884-1039884} {IF} {Mouse}
Models and Analysis of Atherosclerosis, Restenosis, and Aneurysm Formation in the Mouse
. Rosenfeld, M.E., Polinsky, P., Virmani, R., Kauser, K., Rubanyi, G., and Schwartz, S.M. 2000. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler. Thromb. Vasc
Generation of Spatio‐Temporally Controlled Targeted Somatic Mutations in the Mouse
Feil, R. 2007. Conditional somatic mutagenesis in the mouse using site‐specific recombinases. Handb. Exp. Pharmacol. 178:3‐28. Feil, R., Wagner, J., Metzger, D
The OP9-DL1 System: Generation of T-Lymphocytes from Embryonic or Hematopoietic Stem Cells In Vitro
9 cells and expertise with us. These protocols were developed with support from the Canadian Institutes of Health Research and with funds from the Canadian Cancer Society. REFERENCES Awong, G., La Motte-Mohs, R.N., and Zúñiga-Pflücker, J.C. 2008
技术资料暂无技术资料 索取技术资料





